Skip to main content

Michael Redmond

Equibles does not estimate personal net worth.

About Michael Redmond

Michael Redmond is recorded as CEO at Oragenics Inc (OGEN) since February 12, 2024. Oragenics Inc reported in an 8-K filed February 12, 2024 that Michael Redmond was appointed Interim Principal Executive Officer, effective February 12, 2024. Oragenics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Oragenics Inc includes Dr. Alan (CEO), Dr. Alan Joslyn (CEO), Janet Huffman (CEO and CFO) and 7 others.

“effective February 12, 2024, the Board appointed Michael Redmond, the Company's President, as the Company's Interim Principal Executive Officer.”
Oragenics Inc Form 8-K, filed February 12, 2024 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

CEO

2024-02-12–present

Leadership on record at Oragenics Inc

Recent activity